Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.
Over the last three months, scientists have been tracing rare instances of blood clots in veins in connection to the AstraZeneca COVID vaccine - now, they have the first evidence of arterial blood clots, which can cause stroke.
Justin Nogarede, FEPS Digital Policy Analyst, says that while digital tech can’t solve everything, can it solve anything? Read on to find out about the role of digital tech in the COVID-19 pandemic.
Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".
European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.
European Public Health Association Executive Director, Dineke Zeegers Paget, updates us about COVID-19 and its impact on society, public health, healthcare and equitable access to vaccines.
A new study has found that the second dose of the Pfizer vaccine produces a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks.
On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.
Adam Enterkin, Global SVP Sales at BlackBerry, explores the critical role of secure crisis communications for the vaccine rollout and the value of a communication strategy to combat misinformation.
